Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic β-cell destruction in insulin-dependent diabetes mellitus
- 31 May 1993
- Vol. 5 (3) , 185-191
- https://doi.org/10.1016/1043-4666(93)90003-n
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Interleukin-1β induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic isletsBiochemical and Biophysical Research Communications, 1992
- Role of Receptor Binding and Gene Transcription for Both of Stimulatory and Inhibitory Effects of Interleukin-1 In Pancreatic β-CellsAutoimmunity, 1992
- Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitorLife Sciences, 1991
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in miceBiochemical and Biophysical Research Communications, 1991
- Induction of nitric oxide synthase by cytokines in vascular smooth muscle cellsFEBS Letters, 1990
- Insulin‐secreting β‐cells possess specific receptors for interleukin‐1βFEBS Letters, 1990
- A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic isletsJournal of Autoimmunity, 1989
- Cytokines as Immune Effector Molecules in Autoimmune Endocrine Diseases with Special Reference to Insulin-Dependent Diabetes MellitusAutoimmunity, 1989
- Descriptive and mechanistic considerations of interleukin 1 and insulin secretionDiabetes, 1988